Showing 281-290 of 327 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A glucose-responsive cannula of insulin delivery | Cornell University | Bo Wang | Improving Lives | 01-March-2023 to 28-February-2025 | $198,731.24 |
| Convergency, LLC Consulting Agreement | Convergency | Larry Soler | Transportfolio | 01-March-2025 to 28-February-2026 | $60,000.00 |
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-March-2026 | $900,000.00 |
| ALIGN-T1D Start-Up Secretariat | Clinton Health Access Initiative (CHAI) | Nine Steensma | Mission | 01-October-2025 to 31-March-2027 | $2,348,396.21 |
| T1D Global Access Grand Strategy | Clinton Health Access Initiative (CHAI) | Nine Steensma | Mission | 01-August-2024 to 30-September-2025 | $1,179,001.50 |
| Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria | Clinton Health Access Initiative (CHAI) | Margaret Prust | Mission | 01-September-2023 to 31-August-2026 | $1,702,076.57 |
| Spotlight-AQ 2 Center RCT | Children's Mercy Hospital | Cintya Schweisberger | Improving Lives | 01-September-2023 to 31-August-2026 | $710,434.16 |
| Leveraging humoral immunity to promote commensal microbial protection from T1D | Children's Hospital of Philadelphia | Michael Silverman | Cures | 01-May-2020 to 30-April-2025 | $749,994.60 |
| Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2022 to 31-May-2026 | $600,000.00 |
| microRNA-146a is a potential therapeutic target for type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2024 to 31-May-2027 | $600,000.00 |